Salivary duct carcinoma
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD medical weight loss NYC and sleep center NYC
| Salivary duct carcinoma | |
|---|---|
| Synonyms | SDC |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Swelling in the salivary gland, pain, facial nerve dysfunction |
| Complications | Metastasis, facial nerve paralysis |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | Primary tumor, metastatic |
| Causes | Genetic mutations, radiation exposure |
| Risks | Smoking, radiation therapy |
| Diagnosis | Biopsy, imaging studies |
| Differential diagnosis | Mucoepidermoid carcinoma, adenoid cystic carcinoma |
| Prevention | Avoidance of risk factors |
| Treatment | Surgery, radiation therapy, chemotherapy |
| Medication | Chemotherapeutic agents |
| Prognosis | Generally poor prognosis |
| Frequency | Rare |
| Deaths | High mortality rate |
Salivary Duct Carcinoma (SDC) is a rare and aggressive form of cancer that originates in the ducts of the salivary glands. It is known for its rapid growth, potential to metastasize, and a high rate of recurrence. This malignancy represents a significant challenge in terms of diagnosis and management, making it a critical subject of study in the field of oncology and head and neck surgery.
Epidemiology
SDC is uncommon, accounting for less than 10% of all salivary gland neoplasms. It predominantly affects older adults, with a higher incidence in males than in females. The most common site for SDC is the parotid gland, followed by the submandibular gland and minor salivary glands scattered throughout the mucosa of the mouth and throat.
Etiology
The exact cause of SDC is not well understood. However, several risk factors have been identified, including prior radiation exposure to the head and neck region, smoking, and certain genetic predispositions. It is also associated with mutations in oncogenes and tumor suppressor genes, although the specific pathways involved are still under investigation.
Clinical Presentation
Patients with SDC typically present with a rapidly enlarging mass in the affected salivary gland. Pain, facial nerve palsy, and skin involvement may also be observed, indicating a more advanced disease. Due to its aggressive nature, SDC may metastasize to regional lymph nodes and distant organs, such as the lungs and bones, at the time of diagnosis.
Diagnosis
The diagnosis of SDC involves a combination of clinical examination, imaging studies, and histopathological analysis. Imaging techniques such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) are used to assess the extent of the disease. Fine-needle aspiration (FNA) biopsy or open biopsy is performed to obtain tissue samples for histological examination, which is crucial for confirming the diagnosis.
Treatment
The mainstay of treatment for SDC is surgical resection with clear margins, often accompanied by neck dissection to address regional lymph node metastasis. Adjuvant radiation therapy is recommended in cases of high-risk features, such as perineural invasion, lymphovascular invasion, and positive surgical margins. The role of chemotherapy is still being explored, with some evidence supporting its use in metastatic or unresectable disease.
Prognosis
The prognosis of SDC is generally poor, with a high rate of local recurrence and distant metastasis. The overall survival rate varies, but it is significantly lower compared to other salivary gland tumors. Factors that negatively impact prognosis include advanced stage at diagnosis, high-grade histology, and the presence of lymph node involvement.
Research and Future Directions
Ongoing research is focused on understanding the molecular mechanisms underlying SDC, which may lead to the development of targeted therapies. Clinical trials are also underway to evaluate the efficacy of novel therapeutic agents and treatment strategies.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD